Cargando…

Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women

SUMMARY: The study examined long-term direct and indirect economic burden of osteoporotic fractures among postmenopausal women. Healthcare costs among fracture patients were substantial in first year after fracture and remained higher than fracture-free controls for 5 years which highlight needs for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Oth, Silverman, Stuart, Xu, Xiaoqing, Bonafede, Machaon, Fox, Kathleen, McDermott, Michele, Gandra, Shravanthi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128807/ https://www.ncbi.nlm.nih.gov/pubmed/33411007 http://dx.doi.org/10.1007/s00198-020-05769-3

Ejemplares similares

Correction to: Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women
por: Tran, Oth, et al.
Publicado: (2022)

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting
por: Bonafede, Machaon, et al.
Publicado: (2013)

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States
por: Soliman, Ahmed M., et al.
Publicado: (2018)

Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study
por: Fox, Kathleen M., et al.
Publicado: (2016)

Economic burden of osteoporotic fractures in Austria
por: Dimai, Hans Peter, et al.
Publicado: (2012)

The direct and indirect costs of adult atopic dermatitis
por: Manjelievskaia, Janna, et al.
Publicado: (2021)

Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study
por: Fox, Kathleen M, et al.
Publicado: (2012)

Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
por: Polsky, Daniel, et al.
Publicado: (2012)

Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US
por: Bonafede, Machaon M, et al.
Publicado: (2013)

The burden of cystic fibrosis in the Medicaid population
por: Hassan, Mariam, et al.
Publicado: (2018)

Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy
por: Bonafede, Machaon M., et al.
Publicado: (2019)

Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures
por: Song, Xue, et al.
Publicado: (2015)

Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritis
por: Marshall, Alexander, et al.
Publicado: (2019)

Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
por: Johnson, Barbara H., et al.
Publicado: (2015)

Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis
por: Bonafede, Machaon, et al.
Publicado: (2021)

Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective
por: Moayyeri, A., et al.
Publicado: (2023)

Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
por: Fox, Robert J., et al.
Publicado: (2022)

Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Estimation of Cachexia among Cancer Patients Based on Four Definitions
por: Fox, Kathleen M., et al.
Publicado: (2009)

Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls
por: Bedenbaugh, Angela V, et al.
Publicado: (2021)

A health economic analysis of osteoporotic fractures: who carries the burden?
por: Hansen, Louise, et al.
Publicado: (2013)

Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. Data
por: Gharaibeh, Mahdi, et al.
Publicado: (2020)

Inflammatory response in postmenopausal osteoporotic fracture healing
por: Chow, Simon K-H., et al.
Publicado: (2020)

Audiovestibular Symptoms in Osteoporotic Postmenopausal Dominican Women
por: Acra-Tolari, Ricardo, et al.
Publicado: (2022)

Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives
por: Miller, Jeffrey D, et al.
Publicado: (2015)

The Economic Burden of Severe Osteoporotic Fractures in the French Healthcare Database: The FRACTOS Study
por: Thomas, Thierry, et al.
Publicado: (2022)

Economic burden of migraine in Latvia and Lithuania: direct and indirect costs
por: Lublóy, Ágnes
Publicado: (2019)

Tumor Necrosis Factor-Blocker Dose Escalation in Rheumatoid Arthritis Patients in a Pharmacy Benefit Management Setting
por: Blume, Steven W., et al.
Publicado: (2013)

A Linked Electronic Medical Record-Claims Analysis of the Clinical and Economic Outcomes of Patients Coded for Erosive Esophagitis in the United States
por: Yadlapati, Rena, et al.
Publicado: (2023)

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk
por: Quek, Ruben G W, et al.
Publicado: (2015)

Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives
por: Miller, Jeffrey D., et al.
Publicado: (2015)

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women
por: Neuprez, Audrey, et al.
Publicado: (2007)

Clinical manifestations of osteoarthritis in osteoporotic and osteopenic postmenopausal women
por: Rizou, Stavroula, et al.
Publicado: (2018)

Use of health-related quality of life measures to predict health utility in postmenopausal osteoporotic women: results from the Multiple Outcomes of Raloxifene Evaluation study
por: Burge, Russel, et al.
Publicado: (2013)

Economic burden of smoking: a systematic review of direct and indirect costs
por: Rezaei, Satar, et al.
Publicado: (2016)

Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study
por: Cong, Ze, et al.
Publicado: (2022)

SUN-389 Trends in Osteoporosis Treatment Uptake and Persistence Among Postmenopausal Women in the U.S., 2010–2015
por: Kim, Min, et al.
Publicado: (2020)

Sympathetic Skin Response and Vasomotor Symptoms in Postmenopausal Osteoporotic Women
por: Ashraf, Alireza, et al.
Publicado: (2015)

Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis
por: Long, Guanghua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4g55r9pd5j82qat8ghbud715k